State of New Jersey Common Pension Fund D - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 268 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$2,113,585
-19.2%
81,323
-11.1%
0.01%
+12.5%
Q1 2024$2,615,298
-1.2%
91,444
+5.7%
0.01%
-11.1%
Q4 2023$2,647,879
+5.9%
86,532
-7.0%
0.01%0.0%
Q3 2023$2,501,167
-0.8%
93,084
+31.7%
0.01%0.0%
Q2 2023$2,520,092
+40.4%
70,6700.0%0.01%
+50.0%
Q1 2023$1,795,018
-44.1%
70,670
-10.8%
0.01%
-50.0%
Q4 2022$3,213,488
+45.1%
79,228
+18.3%
0.01%
+33.3%
Q3 2022$2,214,000
-6.1%
66,9830.0%0.01%0.0%
Q2 2022$2,358,000
-17.1%
66,983
+8.3%
0.01%0.0%
Q1 2022$2,844,000
-30.6%
61,8360.0%0.01%
-25.0%
Q4 2021$4,100,000
+1.5%
61,836
-4.4%
0.01%
-7.7%
Q3 2021$4,039,000
-21.1%
64,696
+4.7%
0.01%
-23.5%
Q2 2021$5,117,000
+26.3%
61,781
+1.1%
0.02%
+21.4%
Q1 2021$4,051,000
-18.8%
61,097
-6.1%
0.01%
-22.2%
Q4 2020$4,991,000
+67.2%
65,042
-6.2%
0.02%
+50.0%
Q3 2020$2,985,000
-3.0%
69,321
-2.7%
0.01%
-7.7%
Q2 2020$3,076,000
+70.4%
71,217
+13.5%
0.01%
+44.4%
Q1 2020$1,805,000
-54.6%
62,7540.0%0.01%
-40.0%
Q4 2019$3,980,000
+66.7%
62,754
-25.9%
0.02%
+66.7%
Q3 2019$2,387,00084,7000.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders